New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2013
10:00 EDTMDRX, LNC, OII, NOK, EXPD, JBHT, RIMG, WLT, RSH, GOOG, EIX, EME, DRI, BIIB, GTEOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Allscripts (MDRX) upgraded to Outperform from Neutral at Credit Suisse... Biogen (BIIB) upgraded to Buy from Hold at Canaccord... Darden (DRI) upgraded to Neutral from Underperform at BofA/Merrill... EMCOR Group (EME) upgraded to Buy from Hold at KeyBanc... Edison International (EIX) upgraded to Buy from Neutral at SunTrust... Google (GOOG) upgraded to Buy from Neutral at BofA/Merrill... RadioShack (RSH) upgraded to Market Perform from Underperform at Raymond James... Walter Energy (WLT) upgraded to Outperform from Sector Perform at Iberia... Rimage (RIMG) upgraded to Buy from Neutral at Dougherty... J.B. Hunt (JBHT) upgraded to Outperform from Market Perform at Avondale... Expeditors (EXPD) upgraded to Outperform from Market Perform at Avondale... Nokia (NOK) upgraded to Buy from Hold at Argus... Oceaneering (OII) upgraded to Buy from Neutral at Sterne Agee... Lincoln National (LNC) upgraded to Buy from Neutral at BofA/Merrill... Google (GOOG) upgraded at BofA/Merrill... Gran Tierra Energy (GTE) upgraded to Overweight from Neutral at JPMorgan.
News For MDRX;BIIB;DRI;EME;EIX;GOOG;RSH;WLT;RIMG;JBHT;EXPD;NOK;OII;LNC;GTE From The Last 14 Days
Check below for free stories on MDRX;BIIB;DRI;EME;EIX;GOOG;RSH;WLT;RIMG;JBHT;EXPD;NOK;OII;LNC;GTE the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
April 14, 2014
08:35 EDTJBHTJ.B. Hunt expands Simpson's title to Chief Marketing Officer
Subscribe for More Information
08:33 EDTJBHTJ.B. Hunt reports Q1 EPS 58c, consensus 62c
Subscribe for More Information
07:33 EDTBIIBBiogen to present Plegridy, Tecfidera data at AAN annual meeting
Subscribe for More Information
07:06 EDTGOOGU.S. Geospatial Intelligence Foundation to hold a symposium
GEOINT 2013 Symposium, originally scheduled for October 2013, is being held in Tampa, Florida on April 14-17.
06:11 EDTGOOGIntel works with HzO to enhance water resistance in products, DigiTimes says
Subscribe for More Information
05:46 EDTLNCLincoln National upgraded to Strong Buy from Outperform at Raymond James
Subscribe for More Information
April 13, 2014
20:11 EDTGOOGGoogle, Palo Alto, Cvent worth looking into, Barron's says
Subscribe for More Information
16:04 EDTDRIDarden sued by investors on corporate bylaws, WSJ says
Subscribe for More Information
April 11, 2014
13:45 EDTDRIDarden responds to ISS, Glass, Lewis reports
Subscribe for More Information
10:15 EDTBIIBBiogen heads for test of $280 area
The shares are heading lower after an early bounce attempt and are now just above the session low at $280.13. As noted yesterday, a break below $280 would confirm topping in the shares. Support below $280 is at $273.45. Resistance is at $285.
06:43 EDTGOOGGoogle enhancing Android security with apps checks, Re/code says
Subscribe for More Information
06:29 EDTGOOGGoogle says 'Jelly Bean' affected by Heartbleed
Subscribe for More Information
05:57 EDTGOOGCisco, Juniper say some products affected by Heartbleed bug, WSJ reports
Both Cisco (CSCO) and Juniper (JNPR) have disclosed that some of their products are affected by the Heartbleed bug, the Wall Street Journal reports. The companies say the security flaw affects routers, switches and firewalls used by businesses. Reference Link
April 10, 2014
15:13 EDTBIIBBiogen tumbles, nearing important test of support
Subscribe for More Information
13:58 EDTGOOGGoogle to let any U.S. resident buy Google Glass, The Verge says
Subscribe for More Information
09:00 EDTBIIBBiogen May volatility elevated at 43 into Q1 and revenue outlook
Subscribe for More Information
07:31 EDTBIIBBiogen names Adam Koppel as SVP, Chief Strategy Officer
Subscribe for More Information
07:08 EDTBIIBBiogen announces positive top-line efficacy, safety results from Phase 3 trial
Biogen Idec and Swedish Orphan Biovitrum AB released positive top-line results of the Kids A-LONG Phase 3 clinical study that evaluated the safety and efficacy of Eloctate, an investigational recombinant factor VIII Fc fusion protein product candidate, in children with severe haemophilia A. Eloctate was generally well-tolerated and no inhibitors were detected. Efficacy analyses showed twice-weekly prophylactic dosing with Eloctate maintained low bleeding rates in children.
06:49 EDTGOOGMotorola Mobility names Osterloh COO
Subscribe for More Information
06:29 EDTGOOGAT&T in talks to bring ultrafast internet to North Carolina, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use